Table 2.
ECT2 expression is an independent prognostic factor for breast cancer patients (HBreD145Su01)
| Variables | Univariate analysis | Variable selection | ||
|---|---|---|---|---|
| HR (95%CI) | P Value | HR (95%CI) | P value | |
| Age | 0.998 (0.970–1.027) | 0.895 | ||
| Tumor location (left vs. right) | 2.077 (0.930–4.638) | 0.074 | ||
| Grade (grade 2 vs. 1) | 1.575 (0.620–3.999) | 0.339 | ||
| TNM stage (III–IV vs. I–II) | 1.979 (0.988–3.966) | 0.054 | ||
| ER (ER+ vs. ER−) | 0.348 (0.157–0.768) | 0.009 | 0.414 (0.185–0.927) | 0.032 |
| PR (PR+ vs. PR−) | 0.385 (0.173–0.858) | 0.020 | ||
| Her2 (Her2+ vs. Her2−) | 0.906 (0.338–2.428) | 0.845 | ||
| ECT2 level (high vs. low) | 6.198 (2.129–18.043) | 0.0001 | 4.899 (1.668–14.385) | 0.004 |